VivoSim Labs Announces First Commercial Sales In China For Its NAMkind Testing Services
, Inc. (NASDAQ:VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced its first commercial sales in China, opening a
VivoSim Labs just made its first sale of testing services in China, which is a big new market for the company. This shows the company is growing into new places, so watch whether they keep landing more customers there.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.